tweetindex
ES

Ethan Perlstein 1-to-N ✓

@eperlste · Bicoastal · joined 12 Jan 2011

ceo @1000cures, ceo @PerlaraPBC (w16 @ycombinator), founder @metabolisbio

19 295Followers
1 870Following
62 780Posts total
217.9KViews on collected posts

Últimas publicaciones

may god bless the investors who actually follow through with warm intros to other investors 1.1K views · 14 likes · 0 reposts · 2 replies Open on X →
@eperlste Don't forget the tax credits for the trials 789 views · 1 likes · 0 reposts · 0 replies Open on X →
sf guys to sf girls rn sorry ladies no time for bangbang we need to save civilization 961 views · 8 likes · 0 reposts · 1 replies Open on X →
u should see the cookie jar https://t.co/9L92SLfuKL
639 views · 0 likes · 0 reposts · 0 replies Open on X →
@eperlste So good 918 views · 2 likes · 0 reposts · 1 replies Open on X →
@eperlste are these markets too small for large pharma? 743 views · 0 likes · 0 reposts · 1 replies Open on X →
all of biotech: god i wish we could have clinical trial abundance… rare genetic diseases: hi all of biotech: if only there were ultra-fast and low-cost in-human clinical trial validation loops that we could leverage in the US under existing regulatory frameworks… rare 19.3K views · 106 likes · 14 reposts · 10 replies Open on X →
@eperlste https://t.co/nCrh25Mo4o 65 views · 2 likes · 0 reposts · 0 replies Open on X →
@eperlste hell yea. sending a referral. god bless. 107 views · 2 likes · 0 reposts · 0 replies Open on X →
@eperlste Great! And much needed Signed, entrepreneurial rare disease parent 248 views · 4 likes · 1 reposts · 0 replies Open on X →
I've met so many entrepreneurial rare disease parents over the years that I’ve lost count. They have moved or are moving medical mountains to save their kids and others like them. But rare parent founders get no love from institutional players. Those days are done. Science, 190.1K views · 116 likes · 6 reposts · 15 replies Open on X →
@eperlste 3) typically runs lean so profitability becomes easier 4) Orphan drug = 50% tax credit benefits for trials + priority review voucher 5) golden era for genomics + (sometimes) single path corrections, correlates well with 1990’s easy pickings for oncology (eg BCR ABL C 3K views · 6 likes · 0 reposts · 1 replies Open on X →

Frente a cuentas del mismo tamaño

7 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. llega a mucha gente, pero pocos de esos espectadores reaccionan.

Visualizaciones medianas918esta cuenta924mediana de 10K–100K
Alcance, %4.76%esta cuenta3.62%mediana de 10K–100K
Interacción, %0.33%esta cuenta1.52%mediana de 10K–100K
MétricaEsta cuentaMediana de 10K–100KProporción
Visualizaciones medianas por publicación9189240.99×
Alcance (visualizaciones ÷ seguidores)4.76%3.62%1.31×
Tasa de interacción0.33%1.52%0.21×

Otras cuentas de este rango →   Comparar con otra cuenta →   Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3K15 Oct
190.1K17 Apr
248
10718 Apr
6519 Apr
19.3K9 Sep
743
918
639
96110 Sep
789
1.1K12 Sep

Last 12 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.23%15 Oct
0.07%17 Apr
2.02%
1.87%18 Apr
3.08%19 Apr
0.67%9 Sep
0.13%
0.33%
0.00%
0.94%10 Sep
0.13%
1.51%12 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes65.1%261 in total
Reposts5.2%21 in total
Replies7.7%31 in total
Bookmarks21.9%88 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Cuentas similares